Stephen Picone has extensive experience in enzyme manufacturing and supply chain solutions. As Co-Founder, CEO and Chief Strategy Officer at Enzymatics, Stephen managed the scientific operations, coordinated strategic initiatives and developed the company’s proprietary purification technologies to support high-growth NGS companies. Following the acquisition of Enzymatics by Qiagen, Stephen served as Executive Director of Corporate Development at ArcherDX. Prior to founding Enzymatics, Stephen was a product manager at New England BioLabs, focused on manufacture and quality control of a variety of DNA-modifying enzymes. He is listed as inventor on several patents and patent applications.
Current role
Chief Strategic Officer at Van Andel Institute
Chief Strategic Officer at Digital Domain Holdings Ltd
Chief Strategic Officer at Congress Wealth Management
Chief Strategic Officer at Bit Origin
Chief Strategic Officer at Serenus.AI